Jul 2 |
Unveiling Three US Growth Companies With High Insider Ownership
|
Jun 28 |
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
|
Jun 28 |
Is It Too Late to Buy Iovance Biotherapeutics Stock?
|
Jun 26 |
Iovance Biotherapeutics: Amtagvi Launch Continues Upward
|
Jun 21 |
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
|
Jun 10 |
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
|
May 31 |
Exploring Three US Growth Companies With Substantial Insider Ownership
|
May 24 |
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
|
May 24 |
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
|
May 23 |
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
|